4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,316.67p
   
  • Change Today:
      16.67p
  • 52 Week High: 1,820.00
  • 52 Week Low: 545.00
  • Currency: UK Pounds
  • Shares Issued: 15.48m
  • Volume: 0
  • Market Cap: £203.79m
  • Beta: 0.21

Latest Deals

Traded Action Notifier PriceAmountValue
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,103,288 £14,526,625
Maria Del Pilar de la Huerta 6,667 £87,782
Hansjörg Plaggemars 6,667 £87,782
Timothy Paul McCarthy 2,388 £31,442

Major Shareholders

Notifier** Holding Value*
Wilhelm K. T. Zours 5,071,073 £66,769,128
DELPHI Unternehmensberatung AG 5,071,073 £66,769,128
M&G Plc 4,627,741 £60,931,923
Elevage Medical Technologies Holdings 4,627,741 £60,931,923
Deutsche Balaton AG 4,432,637 £58,363,054
4bb AG 3,665,242 £48,259,020
2invest AG 2,229,083 £29,349,593
Sparta AG 1,351,718 £17,797,620
Latonba AG 757,259 £9,970,577
Franciscus De Busschere 537,255 £7,073,858

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,316.67p
Change Today 16.67p
% Change 1.28 %
52 Week High 1,820.00
52 Week Low 545.00
Volume 0
Shares Issued 15.48m
Market Cap £203.79m
Beta 0.21

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
25.57% below the market average25.57% below the market average25.57% below the market average25.57% below the market average25.57% below the market average
28.00% above the sector average28.00% above the sector average28.00% above the sector average28.00% above the sector average28.00% above the sector average
Price Trend
70.60% above the market average70.60% above the market average70.60% above the market average70.60% above the market average70.60% above the market average
95.92% above the sector average95.92% above the sector average95.92% above the sector average95.92% above the sector average95.92% above the sector average
Income Not Available
Growth
35.67% above the market average35.67% above the market average35.67% above the market average35.67% above the market average35.67% above the market average
35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average

4basebio Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page